tiprankstipranks
Trending News
More News >
Zymeworks Inc (ZYME)
NASDAQ:ZYME

Compare Zymeworks (ZYME) vs. Competitors

Compare
611 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Zymeworks
$23.47
$1.77B
-27.71
67.76%
14 Buy
0 Hold
0 Sell
Strong Buy
Arcus Biosciences
$21.80
$2.70B
-6.35
54.39%
7 Buy
2 Hold
0 Sell
Strong Buy
Replimune Group
$7.04
$552.24M
-1.95
-32.05%
4 Buy
3 Hold
0 Sell
Moderate Buy
Oric Pharmaceuticals
$12.12
$1.18B
-7.00
20.72%
11 Buy
1 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$19.21
$1.95B
-6.48
-1.44%
15 Buy
1 Hold
0 Sell
Strong Buy
Sana Biotechnology
$4.58
$1.22B
-4.72
40.92%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ZYME
Zymeworks
23.47
9.18
64.24%
RCUS
Arcus Biosciences
21.80
7.66
54.17%
REPL
Replimune Group
7.04
-4.81
-40.59%
ORIC
Oric Pharmaceuticals
12.12
2.12
21.20%
NRIX
Nurix Therapeutics
19.21
-0.39
-1.99%
SANA
Sana Biotechnology
4.58
1.66
56.85%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts